SEC Form 4 · accession 0001209191-17-051978
Phio Pharmaceuticals Corp. · PHIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexey Eliseev
Officer — Chief Business Officer
Period of report
Sep 5, 2017
Accepted (ET)
Sep 7, 2017 · 8:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001533040
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001F2 | Sep 5, 2017 | S | 26,181 | $0.5571 | D | 1,100,931 | D | |
| Common stock, par value $0.0001F3 | Sep 6, 2017 | S | 91,907 | $0.5365 | D | 1,009,024 | D | |
| Common stock, par value $0.0001F4 | Sep 7, 2017 | S | 58,712 | $0.5283 | D | 950,312 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2Represents the weighted average sale price. The lowest price at which shares were sold was $0.55 and the highest price at which shares were sold was $0.58.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected.
- F3Represents the weighted average sale price. The lowest price at which shares were sold was $0.525 and the highest price at which shares were sold was $0.561.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected.
- F4Represents the weighted average sale price. The lowest price at which shares were sold was $0.52 and the highest price at which shares were sold was $0.545.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected.